BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 4049331)

  • 1. [Monoclonal antibodies. A new tool in the diagnosis of leukemia and lymphoma].
    Melsom H; Kvaløy S; Beiske K; Funderud S; Marton PF; Godal T; Lie SO
    Tidsskr Nor Laegeforen; 1985 Aug; 105(22):1379-82. PubMed ID: 4049331
    [No Abstract]   [Full Text] [Related]  

  • 2. [Use of monoclonal antibodies. A new era in hematology].
    Obłakowski P
    Acta Haematol Pol; 1983; 14(3-4):219-27. PubMed ID: 6380186
    [No Abstract]   [Full Text] [Related]  

  • 3. Diagnosis and treatment of human leukemias and lymphomas utilizing monoclonal antibodies.
    Nadler LM; Ritz J; Griffin JD; Todd RF; Reinherz EL; Schlossman SF
    Prog Hematol; 1981; 12():187-225. PubMed ID: 7041173
    [No Abstract]   [Full Text] [Related]  

  • 4. ILEX oncology acquires CD52 diagnostic rights for Campath.
    Expert Rev Mol Diagn; 2002 Nov; 2(6):525-6. PubMed ID: 12465444
    [No Abstract]   [Full Text] [Related]  

  • 5. Diagnostic applications of monoclonal antibodies to human cancer.
    Borowitz MJ; Stein RB
    Arch Pathol Lab Med; 1984 Feb; 108(2):101-5. PubMed ID: 6546490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Monoclonal antibodies for the diagnosis of non-Hodgkin's lymphoma and lymphatic leukemia].
    Tsuge I; Ueda R; Ota K
    Nihon Rinsho; 1983 Nov; 41(11):2578-85. PubMed ID: 6608606
    [No Abstract]   [Full Text] [Related]  

  • 7. T-lymphocyte malignancies: recent advances in the understanding of their biology, diagnosis and treatment.
    Parkinson DR; Mier JW
    Clin Immunol Rev; 1983; 2(1):59-121. PubMed ID: 6349892
    [No Abstract]   [Full Text] [Related]  

  • 8. [Identification of lymphatic neoplasms by antibody assay].
    Kikuchi K
    Hokkaido Igaku Zasshi; 1982 May; 57(3):281-6. PubMed ID: 6982214
    [No Abstract]   [Full Text] [Related]  

  • 9. [Sero-epidemiologic study of ATLA (ATL-associated antigen) antibodies in patients with ATL and their relatives].
    Kamihira S; Sakitani M; Ichimaru M; Kinosita K; Ikeda S; Yamada Y; Amagasaki T; Momita S
    Rinsho Ketsueki; 1983 May; 24(5):547-52. PubMed ID: 6604175
    [No Abstract]   [Full Text] [Related]  

  • 10. Immunoregulatory mechanisms: dissection and diagnosis with monoclonal antibodies.
    Goldstein G
    Diagn Immunol; 1983; 1(3):98-9. PubMed ID: 6689622
    [No Abstract]   [Full Text] [Related]  

  • 11. The use of monoclonal antibodies for the diagnosis of intracranial malignancies and the small round cell tumours of childhood.
    Kemshead JT; Coakham HB
    J Pathol; 1983 Nov; 141(3):249-57. PubMed ID: 6663388
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibodies presumably cross-reacting with mouse retrovirus type B and C in the sera of both leukemia-lymphoma and mammary cancer patients.
    Segal-Eiras A; Croce MV; Pasqualini CD
    Arch Geschwulstforsch; 1983; 53(4):321-7. PubMed ID: 6312922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of cell surface membrane antigens common to both human neuroblastoma and leukemia-lymphoma cell lines by a panel of 38 monoclonal antibodies.
    Sugimoto T; Tatsumi E; Kemshead JT; Helson L; Green AA; Minowada J
    J Natl Cancer Inst; 1984 Jul; 73(1):51-7. PubMed ID: 6610792
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Several new monoclonal antibodies directed to human T-cell leukemia antigens.
    Negoro S; Seon BK
    Cancer Res; 1982 Oct; 42(10):4259-62. PubMed ID: 6980703
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical evaluation of hematologic malignancies.
    Miettinen M; Schwarting R; Hyun BH
    Hematol Oncol Clin North Am; 1994 Aug; 8(4):683-701. PubMed ID: 7961286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [10 years' experiences with flow cytometric immunological phenotyping in malignant hematologic diseases].
    Kristensen JS; Hokland P
    Ugeskr Laeger; 1996 Oct; 158(43):6098-102. PubMed ID: 8928296
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Identification of the cell lineage of lymphoid malignant cells with monoclonal antibodies].
    Okawa H; Nonoyama S; Minaguchi J; Takase K; Takagi S; Inada M; Yata J; Kawa-Ha K
    Rinsho Ketsueki; 1987 Jan; 28(1):1-8. PubMed ID: 2437344
    [No Abstract]   [Full Text] [Related]  

  • 18. Development of adult T-cell leukemia-lymphoma (ATL) in two anti-ATL-associated antigen-positive healthy adults.
    Kinoshita K; Hino S; Amagasaki T; Yamada Y; Kamihira S; Ichimaru M; Munehisa T; Hinuma Y
    Gan; 1982 Oct; 73(5):684-5. PubMed ID: 6984681
    [No Abstract]   [Full Text] [Related]  

  • 19. Monoclonal antibodies as diagnostic reagents for the identification and characterization of human tumor antigens.
    Fink LM; Clarke SM
    Prog Clin Pathol; 1984; 9():121-33. PubMed ID: 6364219
    [No Abstract]   [Full Text] [Related]  

  • 20. Antibodies and immunohistochemical evaluation for the diagnosis of hematological malignancies: an overview.
    O'Malley DP; Orazi A
    Methods Mol Biol; 2007; 378():91-123. PubMed ID: 18605081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.